CAMBRIDGE, Mass. (AP) _ Moderna Inc. (MRNA) on Thursday reported second-quarter net income of $2.78 billion, after reporting a loss in the same period a year earlier.

The Cambridge, Massachusetts-based company said it had net income of $6.46 per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $6.01 per share.

The biotechnology company posted revenue of $4.35 billion in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $4.29 billion.

Moderna shares have more than quadrupled since the beginning of the year. The stock has climbed fivefold in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News